MLH1 and cancer: The functional impact of eight hMLH1 variants was determined by evaluating the effect on the mutation rate; three out of five pathogenic variants increased the mutation rate at the URA3 locus (Figure 3B) suggesting that complementation of yeast MMR defect by human corresponding alleles could be proposed as a system to characterize cancer-associated genetic variants [59].